Literature DB >> 28635596

Breast cancer targeted therapy: successes and challenges.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28635596     DOI： 10.1016/S0140-6736(17)31662-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  KCNN4 induces multiple chemoresistance in breast cancer by regulating BCL2A1.

Authors:  Peiyang Lin; Junjing Li; Fugui Ye; Wenfen Fu; Xin Hu; Zhiming Shao; Chuangui Song
Journal:  Am J Cancer Res       Date:  2020-10-01       Impact factor: 6.166

2.  Effects of Prophylactic Administration of Granulocyte Colony-Stimulating Factor on Peripheral Leukocyte and Neutrophil Counts Levels After Chemotherapy in Patients With Early-Stage Breast Cancer: A Retrospective Cohort Study.

Authors:  Wei Tian; Yali Wang; Yunxiang Zhou; Yihan Yao; Yongchuan Deng
Journal:  Front Oncol       Date:  2022-04-25       Impact factor: 5.738

Review 3.  Progress on deep learning in digital pathology of breast cancer: a narrative review.

Authors:  Jingjin Zhu; Mei Liu; Xiru Li
Journal:  Gland Surg       Date:  2022-04

4.  Diagnostic value of MRI combined with ultrasound for lymph node metastasis in breast cancer: Protocol for a meta-analysis.

Authors:  Dechun Cai; Tong Lin; Kailin Jiang; Zhizhong Sun
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

5.  Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens.

Authors:  Feng Xu; Dong Wang; JianXiu Cui; Jie Li; Hongchuan Jiang
Journal:  Cancer Manag Res       Date:  2020-02-11       Impact factor: 3.989

6.  MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6.

Authors:  Lei Wei; Bo Wang; Liwen Hu; Yang Xu; Zhongdong Li; Yi Shen; Hairong Huang
Journal:  Aging (Albany NY)       Date:  2020-11-14       Impact factor: 5.682

7.  Concept Design, Development and Preliminary Physical and Chemical Characterization of Tamoxifen-Guided-Mesoporous Silica Nanoparticles.

Authors:  Candace M Day; Martin J Sweetman; Shane M Hickey; Yunmei Song; Yongjun Liu; Na Zhang; Sally E Plush; Sanjay Garg
Journal:  Molecules       Date:  2021-01-04       Impact factor: 4.411

8.  Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.

Authors:  Bochuan Zhang; Qingfeng Wang; Chenghao Fu; Chunying Jiang; Shiliang Ma
Journal:  Ann Transl Med       Date:  2019-12

Review 9.  Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles.

Authors:  Candace M Day; Shane M Hickey; Yunmei Song; Sally E Plush; Sanjay Garg
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411

10.  Circular RNA hsa_circRNA_002178 silencing retards breast cancer progression via microRNA-328-3p-mediated inhibition of COL1A1.

Authors:  Ting Liu; Ping Ye; Yuanyuan Ye; Sen Lu; Baosan Han
Journal:  J Cell Mol Med       Date:  2020-01-19       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.